Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.29M Buy
14,339
+7,884
+122% +$757K 0.01% 745
2025
Q4
$599K Sell
6,455
-17,087
-73% -$1.86M ﹤0.01% 951
2025
Q3
$2.93M Buy
+23,542
New +$2.99M 0.01% 629
2024
Q2
Sell
-2,921
Closed -$270K 910
2024
Q1
$270K Sell
2,921
-6,039
-67% -$486K ﹤0.01% 662
2023
Q4
$677K Sell
8,960
-2,606
-23% -$169K ﹤0.01% 676
2023
Q3
$701K Buy
11,566
+825
+8% +$56.6K ﹤0.01% 656
2023
Q2
$774K Sell
10,741
-16,607
-61% -$1.05M ﹤0.01% 609
2023
Q1
$1.52M Buy
27,348
+149
+0.5% +$8.22K 0.01% 506
2022
Q4
$1.38M Sell
27,199
-1,264
-4% -$62.5K 0.01% 595
2022
Q3
$1.2M Sell
28,463
-5,286
-16% -$263K 0.01% 667
2022
Q2
$1.67M Buy
33,749
+1,143
+4% +$56.7K 0.01% 714
2022
Q1
$1.72M Buy
32,606
+16,215
+99% +$907K 0.01% 716
2021
Q4
$1.12M Buy
+16,391
New +$1.15M 0.01% 549

Other funds holding ITRI

Ray Dalio's ITRI Position: Q1 2026 in Review

Ray Dalio increased its Itron (ITRI) stake by 122% in Q1 2026, buying an estimated $757K and bringing the position to 14,339 shares worth $1.29M. The position accounts for 0.01% of the portfolio, ranked #745.

Ray Dalio first reported a position in ITRI in Q4 2021 and has held it in 13 quarters since. The position peaked at $2.93M in Q3 2025. 432 funds tracked by Wall St. Rank hold ITRI as of Q1 2026.

  • Ray Dalio held 14,339 shares of Itron worth $1.29M as of Q1 2026.
  • Ray Dalio bought 7,884 Itron shares in Q1 2026, an estimated $757K.
  • Itron made up 0.01% of Ray Dalio's portfolio in Q1 2026, its #745 holding.
  • Ray Dalio first reported a position in Itron in Q4 2021 and has held it in 13 quarters since.
  • Ray Dalio's Itron position peaked at $2.93M in Q3 2025.
  • 432 funds tracked by Wall St. Rank held Itron as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.